ArticleDiabetes2022

Antibody-Mediated Targeting of a Hybrid Insulin Peptide Toward Neonatal Thymic Langerin-Positive Cells Enhances T-Cell Central Tolerance and Delays Autoimmune Diabetes.

Yong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.